Diagnosing and managing acute heart failure in adults: summary of NICE guidance

  title={Diagnosing and managing acute heart failure in adults: summary of NICE guidance},
  author={Katharina Dworzynski and Emmert Roberts and Andrew James Ludman and Jonathan Mant},
  journal={BMJ : British Medical Journal},
Acute heart failure may present de novo in people without known cardiac dysfunction, or as an acute decompensation of known chronic heart failure. Acute heart failure is a common cause of admission to hospital (more than 67 000 admissions in England and Wales each year) and is the leading cause of hospital admission in people aged 65 years or more in the United Kingdom.1 European registry data show that nearly 50% of people admitted to hospital with acute heart failure are re-admitted within 12… Expand
Acute Decompensated Heart Failure: A Pharmacotherapy Approach
Clinical pearls for the optimal use of diuretic, vasodilator, and inotropic therapies, guided by an understanding of the Forrester hemodynamic subsets, are provided to improve fluid status and end-organ perfusion. Expand
Advanced Heart Failure Therapies and Cardiorenal Syndrome.
This chapter discusses the assessment and management of patients with CRS with end-stage HF, and provides a summary of temporary circulatory support devices that can be considered for those whom hospice is not desired. Expand
Concerns about latest NICE guidelines on acute heart failure
The guideline fails to define acute heart failure and to differentiate it from hospital admission for heart failure, and the two conditions are not synonymous. Expand
Echocardiography and lung ultrasonography for the assessment and management of acute heart failure
This Consensus Statement, prepared by the Acute Heart Failure Study Group of the ESC Acute Cardiovascular Care Association, reviews the existing and potential roles of echocardiography and lung ultrasonography in the assessment and management of patients with acute heart failure, highlighting the differences from established practice where relevant. Expand
A contemporary review of peripartum cardiomyopathy
The background, clinical presentation, diagnosis, outcome, prognosis and treatment available for women diagnosed with peripartum cardiomyopathy are discussed. Expand
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group
NIV seems to be the first choice for treatment of ARF due to ACPE, showing high clinical effectiveness and representing a rescue option for patients not improving with conventional oxygen therapy. Expand
Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study
Routine use of supplemental oxygen in AHF patients without hypoxemia was not found to reduce all-cause in-hospital mortality or ICU mortality, and the absence of an effect of supplementary oxygen on mortality was consistent in all subgroups. Expand
Oxygen Therapy in Patients With Acute Heart Failure: Friend or Foe?
Current evidence regarding the cardiovascular effects of supplemental oxygen therapy, particularly evidence from the field of acute heart failure, and delineate knowledge gaps in the field and future directions in research are summarized. Expand
The Biomarker Utility in Risk Stratification in an Ambulatory Heart Failure: ST2 or Galectin-3?
The comment is indicated sST2 and galectin-3 are recommended as alternate biomarkers with defined predictive value in HF and in generally patient population at high risk of HF manifestation. Expand
Optimal Use of Beta-Blockers for Congestive Heart Failure.
  • Hae-Young Lee, S. Baek
  • Medicine
  • Circulation journal : official journal of the Japanese Circulation Society
  • 2016
The effect of β-blockers in various clinical situations is summarized and a strategy for optimal use is suggested. Expand


The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.
Most men but a minority of women who underwent investigation of cardiac function had evidence of moderate or severe left ventricular dysfunction, the main target of current advances in the treatment of heart failure. Expand
The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment
The results suggest that the prescription of recommended medications including ACE inhibitors and beta-blockers remains limited and that the daily dosage remains low, particularly for beta- blockers. Expand
Diuretics and ultrafiltration in acute decompensated heart failure.
This review summarizes available data on the use of both diuretics and UF in ADHF patients and identifies challenges and unresolved questions for each approach. Expand
Acute heart failure: diagnosing and managing acute heart failure in adults. (Clinical Guideline CG187)
  • 2014
National Institute for Health and Clinical Excellence. The guidelines manual
  • 2012
Chronic heart failure: the management of chronic heart failure in adults in primary and secondary care. (Clinical Guideline 108)
  • 2010
Intensive Care Society. Levels of critical care for adult patients
  • ICS
  • 2009